MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jvh.13808

Медицинская библиотека · Journal of viral hepatitis · 2023

A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD.

Wang Jian, Huang Rui, Liu Jiacheng, Lai Ruimin, Liu Yilin, Zhu Chuanwu, Qiu Yuanwang, He Zebao, Yin Shengxia, Chen Yuxin, Yan Xiaomin, Ding Weimao, Zheng Qi, Li Jie, Wu Chao

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

There are still lack of non-invasive models to evaluate liver fibrosis in chronic hepatitis B (CHB) patients with nonalcoholic fatty liver disease (NAFLD). We aimed to establish a predictive model for advanced fibrosis in these patients. A total of 504 treatment-naive CHB patients with NAFLD who underwent liver biopsy were enrolled and randomly divided into a training set (n = 336) and a validation set (n = 168). Receiver operating characteristic (ROC) curve was used to compare predicting accuracy for the different models. One hundred fifty-six patients (31.0%) had advanced fibrosis. In the training set, platelet, prothrombin time, type 2 diabetes, HBeAg positivity and globulin were significantly associated with advanced fibrosis by multivariable analysis. A predictive model namely PPDHG for advanced fibrosis was developed based on these parameters. The areas under the ROC curve (AUROC) of PPDHG with an optimal cut-off value of -0.980 in predicting advanced fibrosis was 0.817 (95% confidence interval 0.772 to 0.862), with a sensitivity of 81.82% and a specificity of 66.81%. The predicting accuracy of PPDHG for advanced fibrosis was significantly superior to AST to platelet ratio index (APRI), fibrosis-4 score (FIB-4) and NAFLD fibrosis score (NFS). Further analysis revealed that the AUROC of PPDHG remained significantly higher than FIB-4 and NFS indexes, while it was comparable with APRI for predicting advanced fibrosis in the validation set. PPDHG had a better predicting performance than established models for advanced fibrosis in CHB patients with NAFLD. The application of PPDHG can reduce the necessary for liver biopsy in these patients.

Для цитирования: Wang Jian, Huang Rui, Liu Jiacheng, Lai Ruimin, Liu Yilin, Zhu Chuanwu, Qiu Yuanwang, He Zebao, Yin Shengxia, Chen Yuxin, Yan Xiaomin, Ding Weimao, Zheng Qi, Li Jie, Wu Chao. A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD.. Journal of viral hepatitis. 2023. DOI: 10.1111/jvh.13808.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.